semaglutide eligibility across all current indications for us adults Gallup | More Americans are using GLP-1 medications weight loss than ever before. Gallup finds that 11% of U.S. currently take a GLP-1 Semaglutide Eligibility Expands to Over

While semaglutide does not directly increase UTI risk, patients can implement evidence-based strategies to minimize infection likelihood during treatment

Learn more Medical Weight Loss Benefits If you have felt stuck in a cycle of yo-yo dieting or found it impossible to lose weight despite eating clean and exercising, know that it is not a failure of willpowerit is often biology

Tirzepatide pregnancy data: Tirzepatide has virtually no published human pregnancy outcome data

Understanding these mechanisms and safety considerations helps patients appreciate why certain effects occur, particularly during the initial treatment phase